BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D' Souza T, Prasad KC. Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. Int J Microbiol 2014;2014:636493. [PMID: 24949016 DOI: 10.1155/2014/636493] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Gits-Muselli M, Hamane S, Verillaud B, Cherpin E, Denis B, Bondeelle L, Touratier S, Alanio A, Garcia-Hermoso D, Bretagne S. Different repartition of the cryptic species of black aspergilli according to the anatomical sites in human infections, in a French University hospital. Med Mycol 2021:myab027. [PMID: 34022772 DOI: 10.1093/mmy/myab027] [Reference Citation Analysis]
2 Sabz G, Gharaghani M, Mirhendi H, Ahmadi B, Gatee MA, Sisakht MT, Hemati A, Mohammadi R, Taghavi J, Nouripour-Sisakht S. Clinical and microbial epidemiology of otomycosis in the city of Yasuj, southwest Iran, revealing Aspergillus tubingensis as the dominant causative agent. J Med Microbiol 2019;68:585-90. [PMID: 30801244 DOI: 10.1099/jmm.0.000948] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
3 Gharaghani M, Seifi Z, Zarei Mahmoudabadi A. Otomycosis in iran: a review. Mycopathologia 2015;179:415-24. [PMID: 25633436 DOI: 10.1007/s11046-015-9864-7] [Cited by in Crossref: 21] [Cited by in F6Publishing: 17] [Article Influence: 3.0] [Reference Citation Analysis]
4 Jimenez-garcia L, Celis-aguilar E, Díaz-pavón G, Muñoz Estrada V, Castro-urquizo Á, Hernández-castillo N, Amaro-flores E. Efficacy of topical clotrimazole vs. topical tolnaftate in the treatment of otomycosis. A randomized controlled clinical trial. Brazilian Journal of Otorhinolaryngology 2020;86:300-7. [DOI: 10.1016/j.bjorl.2018.12.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
5 Mofatteh MR, Ahi Fersheh M, Nikoomanesh F, Namaei MH. Comparing the Therapy of Otomycosis Using Clotrimazole with Iodine Tincture: A Clinical Trial. Iran J Otorhinolaryngol 2021;33:229-35. [PMID: 34395323 DOI: 10.22038/ijorl.2021.51647.2751] [Reference Citation Analysis]
6 Yassine M, Haiet AH. Self-injury in schizophrenia as predisposing factor for otomycosis. Med Mycol Case Rep 2018;21:52-3. [PMID: 30069425 DOI: 10.1016/j.mmcr.2018.05.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Goodale EC, Outerbridge CA, White SD. Aspergillus otitis in small animals - a retrospective study of 17 cases. Vet Dermatol 2016;27:3-e2. [DOI: 10.1111/vde.12283] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
8 Alarid-Coronel J, Celis-Aguilar E, Escobar-Aispuro L, Muñoz-Estrada V. Otomycosis in immunocompetent patients: Clinical and mycological features. Our experience with 40 cases. Clin Otolaryngol 2018;43:373-7. [PMID: 28834405 DOI: 10.1111/coa.12966] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
9 Li Y, He L. Diagnosis and treatment of otomycosis in southern China. Mycoses 2019;62:1064-8. [PMID: 31368588 DOI: 10.1111/myc.12979] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
10 Ahmed MR, Abou-Halawa AS, Hessam WF, Abdelkader DSA. A search for new otomycotic species and their sensitivity to different antifungals. Interv Med Appl Sci 2018;10:145-9. [PMID: 30713753 DOI: 10.1556/1646.10.2018.28] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Chen Q, Chu H, Tao Y, Peng L, Zhou L, Liu L, Wu X. A Comparison of Triamcinolone Acetonide Econazole Cream and Nystatin Suspension in Treatment of Otomycosis. Laryngoscope 2021;131:E1640-6. [PMID: 33141477 DOI: 10.1002/lary.29190] [Reference Citation Analysis]
12 Agarwal P, Devi LS. Otomycosis in a Rural Community Attending a Tertiary Care Hospital: Assessment of Risk Factors and Identification of Fungal and Bacterial Agents. J Clin Diagn Res 2017;11:DC14-8. [PMID: 28764159 DOI: 10.7860/JCDR/2017/25865.10068] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
13 Mahdavi Omran S, Yousefzade Z, Khafri S, Taghizadeh-Armaki M, Kiakojuri K. Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis. Curr Med Mycol 2018;4:18-23. [PMID: 30186989 DOI: 10.18502/cmm.4.1.30] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Sangaré I, Amona FM, Ouedraogo RW, Zida A, Ouedraogo MS. Otomycosis in Africa: Epidemiology, diagnosis and treatment. J Mycol Med 2021;31:101115. [PMID: 33516991 DOI: 10.1016/j.mycmed.2021.101115] [Reference Citation Analysis]